Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment

Liver cancer is the second leading cause of cancer‐related deaths, and hepatocellular carcinoma (HCC) is the most common type. Therefore, molecular targets are urgently required for the early detection of HCC and the development of novel therapeutic approaches. Glypican‐3 (GPC3), an oncofetal proteo...

Full description

Saved in:

Bibliographic Details
Published in:	Medicinal research reviews Vol. 38; no. 2; pp. 741 - 767
Main Authors:	Zhou, Fubo, Shang, Wenting, Yu, Xiaoling, Tian, Jie
Format:	Journal Article
Language:	English
Published:	United States Wiley Subscription Services, Inc 01.03.2018
Subjects:	Biomarkers, Tumor - metabolism Carcinoma, Hepatocellular - blood Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Disease Progression Glypicans - blood Glypicans - chemistry Glypicans - metabolism glypican‐3 hepatocellular carcinoma Humans Liver cancer Liver Neoplasms - blood Liver Neoplasms - diagnosis Liver Neoplasms - pathology Liver Neoplasms - therapy Medical imaging Molecular Targeted Therapy glypican-3 hepatocellular carcinoma
ISSN:	0198-6325, 1098-1128, 1098-1128
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!